Bill Blair

Bill Blair serves as a Non Executive Director at Polarean, focusing on the commercialisation of the proprietary hyper-polarised MRI contrast agent, Xenoview TM, for lung function imaging. Blair is also an active member of the Investment Advisory Board for the WAPG Pioneer Life Sciences Fund, which supports early-stage life science companies. As a Non Executive Director at Iksuda Therapeutics, Blair contributes to the development of advanced Antibody Drug Conjugates for cancer treatment. In the role of Non Executive Director and Chair of the Audit Committee for North East Finance (Holdco) Limited, Blair oversees the management of a venture capital and loan fund investing in North East England SMEs. Blair's experience includes directorial positions at HVS Advisers Ltd, Alderley Park Ventures, and Bridge Valley Ventures Fund I, focusing on strategic financial advice and fund management in the life sciences sector. Previous roles include Founding Executive Director of Sunergos Innovations, Head of Business Creation at Edinburgh BioQuarter, and Founder of UB Pharma, demonstrating a strong track record in fostering innovation and securing funding within the life sciences field.